89 results
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
23 Feb 21
Company Continues to Execute Strategic Transformation Plan
4:15pm
execution and a more stable pricing environment.
◦Total test volumes of 224,000 declined 5% year-over-year but increased 7% sequentially. Average revenue … per test declined 1% sequentially, demonstrating an increasingly stable pricing environment for the company’s products and was driven by mix shift
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
10 Sep 20
Myriad Genetics Expands Board of Directors with New Member
7:24am
strategic insights in executing our global strategy for molecular diagnostics and precision medicine in a dynamic and changing business environment … environment; and the Company’s strategic directives under the caption “About Myriad Genetics.” These “forward-looking statements” are based on management’s
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
4 Nov 08
Results of Operations and Financial Condition
12:00am
sample flow continues to be very strong, despite the current economic environment. We attribute this healthy demand to the clinical value of our … the current economic environment; and continued healthy demand attributable to the essential clinical value of the results of our molecular diagnostic
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
3 Nov 09
Myriad Genetics Reports First Quarter
12:00am
in the same period last year. While the weak economic environment continued to restrain overall revenue growth compared to the prior year, the Company has … ; the ongoing performance and show of results from our direct-to-consumer marketing campaigns; the future impact of the weak economic environment on revenue
8-K
EX-99.1
c61 j4wqnj8glmfllg
3 May 21
Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives
4:05pm
8-K
EX-10.1
o8xvekk3tr y0
9 Oct 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
cyaayw8w0
23 Mar 20
Myriad Announces Board of Directors Leadership Transition
7:16am
8-K
EX-99.1
6afhi
2 Nov 10
Fiscal 2011 First Quarter Financial Results
12:00am
8-K
EX-99.1
g9ze6kug km
10 Aug 10
Myriad Genetics Reports Fiscal 2010 Financial Results
12:00am
8-K
EX-99.2
qj02vpp8e
23 Feb 21
Company Continues to Execute Strategic Transformation Plan
4:15pm
8-K
EX-99.1
vhgrz y56icyjyirhl
3 Aug 21
Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans
7:05am
8-K
EX-99.1
15gkzr99s2e6z0g5t
9 Nov 20
Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter
8:02am
8-K
EX-99.1
o0sgqrodki7vfw7u 40
2 Nov 21
Continues Strong Execution of Strategic Growth & Transformation Plans
8:40am
8-K
EX-99.1
0p3v78st1
5 May 22
Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022
7:05am